Journal of Clinical Epidemiology
Volume 54, Issue 7 , Pages 702-709 , July 2001

Risk factors for neuroblastoma at different stages of disease. Results from a population-based case-control study in Germany

Received 10 December 1999 ,Revised 15 September 2000 ,Accepted 21 September 2000.

References 

  1. German Childhood Cancer Registry (GCCR). Annual report 1999. Technical Report, Institute for Medical Statistics and Documentation, University of Mainz, 2000.
  2. van Hoff J, Schymura MJ, McCrea Curnen MG. Trends in the incidence of childhood and adolescent cancer in Connecticut. Med Pediatr Oncol. 1988;16:78–87
  3. Carlsen NLT. Epidemiological investigations on neuroblastomas in Denmark 1943–1980. Br J Cancer. 1986;54:977–988
  4. Gurney JG, Davis S, Severson RK, Fang JY, Ross JA, Robison LL. Trends in cancer incidence among children in the US. Cancer. 1996;78:532–541
  5. Michaelis J, Haaf HG, Zöllner J, Kaatsch P, Krummenauer F, Berthold F. Case control study of neuroblastoma in west-Germany after the Chernobyl accident. Klin Padiatr. 1996;208:172–178
  6. Schilling FH, Spix C, Berthold F, Erttmann R, Hero B, Michaelis J, et al. German neuroblastoma mass screening study at 12 months of age (statistical aspects and preliminary results). Med Pediatr Oncol. 1998;;31:435–441(special issue)
  7. German Childhood Cancer Registry (GCCR). Annual Report 1998. Technical Report, Institute for Medical Statistics and Documentation, University of Mainz, 1999 [WWW: http://www.info.imsd.uni-mainz.de/K_Krebsregister].
  8. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD, White PS. Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol. 1997;19:93–101
  9. Katzenstein HM, Cohn SL. Advances in the diagnosis and treatment of neuroblastoma. Curr Opin Oncol. 1998;10:43–51
  10. Carlsen NLT. Neuroblastomas presenting in the first year of life (epidemiological differences from those presenting at older ages). Cancer Detect Prev. 1996;20:251–261
  11. Kaatsch P, Kaletsch U, Krummenauer F, Meinert R, Miesner A, Haaf G, et al. Case control study on childhood leukemia in Lower Saxony, Germany. Klin Padiatr. 1996;208:179–185
  12. Meinert R, Kaatsch P, Kaletsch U, Krummenauer F, Miesner A, Michaelis J. Childhood leukaemia and exposure to pesticides (results of a case-control study in northern Germany). Eur J Cancer. 1996;32A:1943–1948
  13. Kaatsch P, Kaletsch U, Meinert R, Miesner A, Hoisl M, Schüz J, et al. German case control study on childhood leukemia—basic considerations, methodology and summary of the results. Klin Padiatr. 1998;210:185–191
  14. Schüz J, Kaletsch U, Meinert R, Kaatsch P, Michaelis J. Association of childhood leukaemia with factors related to the immune system. Br J Cancer. 1999;80:585–590
  15. Schüz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J. Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol. 1999;28:631–639
  16. Meinert R, Kaletsch U, Kaatsch P, Schüz J, Michaelis J. Associations between childhood cancer and ionizing radiation. Results of a population-based case-control study in Germany. Cancer Epidemiol Biomarkers Prev. 1999;8:793–799
  17. Meinert R, Schüz J, Kaletsch U, Schüz J, Michaelis J. Leukemia and non-Hodgkin lymphoma in childhood and exposure to pesticides—results of a register-based case-control study in Germany. Am J Epidemiol. 2000;151:639–646
  18. Buckley JD, Buckley CM, Ruccione K, Sather HN, Waskerwitz MJ, Woods WG, et al. Epidemiological characteristics of childhood acute lymphocytic leukemia. Analysis by immunophenotype. The Children's Cancer Group. Leukemia. 1994;8:856–864
  19. Neuhäuser M, Becher H. Improved odds ratio estimation by post hoc stratification of case-control data. Stat Med. 1997;16:993–1004
  20. Brookmeyer R, Liang KY, Linet M. Matched case-control designs and overmatched analyses. Am J Epidemiol. 1986;124:693–701
  21. SAS Institute . SAS/STAT user's guide. Vol 1. 4th ed. Cary, NC: SAS Institute; 1994;
  22. Brodeur GM, Pritchard J, Berthold F, Carlsen NL, Castel V, Castelberry RP, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:1466–1477
  23. Kaatsch P, Haaf G, Michaelis J. Childhood malignancies in Germany—methods and results of a nationwide registry. Eur J Cancer. 1995;31A:993–999
  24. Davis S, Rogers MAM, Pendergrass TW. The incidence and epidemiologic characteristics of neuroblastoma in the United States. Am J Epidemiol. 1987;126:1063–1074
  25. Little J. Epidemiology of childhood cancer. Lyon, France: IARC Scientific Publications; 1999;
  26. Satge D, Sasco AJ, Carlsen NLT, Stiller CA, Rubie H, Hero B, et al. A lack of neuroblastoma in Down syndrome (a study from 11 European countries). Cancer Res. 1998;58:448–452
  27. Kramer S, Ward E, Meadows AT, Malone KE. Medical and drug risk factors associated with neuroblastoma (a case-control study). J Natl Cancer Inst. 1987;78:797–804
  28. Michalek AM, Buck GM, Nasca PC, Freedman AN, Baptiste MS, Mahoney MC. Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol. 1996;143:996–1001
  29. Schwartzbaum JA. Influence of the mother's prenatal drug consumption on risk of neuroblastoma in the child. Am J Epidemiol. 1992;135:1358–1367
  30. Olshan AF, Smith J, Cook MN, Grufferman S, Pollock BH, Stram DO, et al. Hormone and fertility drug use and the risk of neuroblastoma (a report from the Children's Cancer Group and the Pediatric Oncology Group). Am J Epidemiol. 1999;150:930–938
  31. Neglia JP, Smithson WA, Gunderson P, King FL, Singher LJ, Robison LL. Prenatal and perinatal risk factors for neuroblastoma. A case-control study. Cancer. 1988;61:2202–2206
  32. Johnson CC, Spitz MR. Neuroblastoma (case-control analysis of birth characteristics). J Natl Cancer Inst. 1985;74:789–792
  33. Bunin GR, Ward E, Kramer S, Rhee CA, Meadows AT. Neuroblastoma and parental occupation. Am J Epidemiol. 1990;131:776–780
  34. Wilkins JR, Hundley VD. Paternal occupational exposure to electromagnetic fields and neuroblastoma in offspring. Am J Epidemiol. 1990;131:995–1008
  35. International Agency for Research on Cancer (IARC) . Formaldehyde IARC Monogr Eval Carcinog Risks Hum. 1995;62:217–375[Published erratum appears in IARC Monogr Eval Carcinog Risks Hum 1996;65:549]
  36. Michaelis J, Schüz J, Meinert R, Zemann E, Grigat JP, Kaatsch P, et al. Combined risk estimates for two German population-based case-control studies on residential magnetic fields and childhood acute leukemia. Epidemiology. 1998;9:92–94
  37. Schüz J, Grigat JP, Störmer B, Rippin G, Brinkmann K, Michaelis J. Extremely-low-frequency magnetic fields in residences in Germany (distribution of measurements, comparison of two methods for assessing exposure, and predictors for the occurrence of magnetic fields above background level). Radiat Environ Biophys. 2000;39:233–240
  38. Tonini GP. Neuroblastoma (a multiple biological disease). Eur J Cancer. 1993;29A:802–804

PII: S0895-4356(00)00339-5

Journal of Clinical Epidemiology
Volume 54, Issue 7 , Pages 702-709 , July 2001

Article Tools